Last Updated: 12/12/2024
Phase 1 & 2: PATH/GSK collaboration to support adoption of best clinical practices for radical cure of Plasmodium vivax in India
Objectives
The objectives of this project were:
- Understand the risks and opportunities associated with access to best clinical practices for managing vivax malaria in India; and
- Support adoption of best clinical practices for radical cure of Plasmodium vivax in India.
Principal Institution
Principal Investigators / Focal Persons
Partner Institutions
Date
Apr 2018 — Oct 2022
Funding Details
Project Site


